Category Archives: Emerging Markets

'Freedom of Thought' Key to Middle East Science Progress

By Jennifer Ringler | Published: March 9, 2011
A new report from Thomson Reuters points to a “rapidly changing context for science and innovation in the Middle East.” The Arabian, Persian and Turkish Middle East may currently produce only 4% of the world’s scientific literature, but the output is growing rapidly, according to a new Global Research Report from Thomson Reuters. Indeed, countries such [...]
Also posted in Global | Tagged , , , , , , , | Leave a comment

Battling Chronic Disease in Mexico

By Jennifer Ringler | Published: February 28, 2011
The objectives of the Workplace Wellness & Prevention Council of Mexico could lead to a win-win situation that may serve as a model for other developing countries around the world. In 2003, Abner Mason started a non-profit in Mexico. The AIDS Responsibility Project’s primary function was to campaign against discrimination of people with AIDS [...]
Also posted in Global, healthcare | Tagged , , | 4 Comments

Croatia: A New Hope for European Pharma?

By Guest Blogger | Published: February 24, 2011
With Croatia’s potential accession to the EU gathering pace, Beth Kennedy looks at the implications for pharma. The growth in overall healthcare expenditure in Croatia is slow and the percentage of GDP is expected to remain the same, but the country’s accession to the EU means that European pharma would have access to cheap products [...]
Also posted in Europe, Global, Guest Blog, Market Access, healthcare | Tagged , , | Leave a comment

Delay to Bribery Act: Breathing Space for UK Pharma?

By Julian Upton | Published: February 9, 2011
Pharma companies anxious about the implications of the imminent UK Bribery Act — which is set to take a hard line on corruption that some might regard as draconian — may be relieved to hear that it has been delayed again. Earlier this month the UK Ministry of Justice announced that its implementation, which was [...]
Also posted in Europe, Global, Regulatory | 1 Comment

New Decade, New Agenda for Pharma

By Guest Blogger | Published: January 12, 2011
A new track for nonprofits, product diversification and the rise of the emerging markets —  Audrey S. Erbes reports on some of the takeaways from this week’s JP Morgan Healthcare Conference. There were some surprising changes in the format of the 29th Annual JP Morgan Healthcare Conference, the world’s premier health care industry investment meeting which [...]
Also posted in Guest Blog, R&D | Tagged , , , , , | Leave a comment